{"id":"https://genegraph.clinicalgenome.org/r/ce5876bb-0bb1-4912-974f-f0522cb3de9dv3.0","type":"EvidenceStrengthAssertion","dc:description":"SGCD was originally evaluated for DCM by the ClinGen DCM GCEP on 22 November 2019. Evidence of the association of this gene with DCM was re-evaluated using SOP v10 on 30th March 2025. As a result, the classification changed from limited to no known disease relationship. A summary of the information contributing to the classification of this gene at the time of re-evaluation is summarized herein. \n\nSGCD was first reported in relation to autosomal dominant dilated cardiomyopathy in 2000 (Tsubata et al, PMID 10974018). Human genetic evidence supporting this gene-disease relationship includes case-level data. At least 30 variants (20 missense, one splice, one nonsense, two frameshift, three deletion and three intronic polymorphisms) have been reported in humans. Though most of these variants are found too commonly to explain disease. Variants in this gene have been reported in at least 33 probands in 11 publications (Tsubata et al, 2000, PMID: 10974018; Karkkainen et al, 2003, PMID: 14564412; Sylvius et al, 2003, PMID: 12794684; Baydar et al, 2016, PMID: 27488758; Bauer et al, 2009, PMID: 19259135; Chen et al, 2015, PMID: 26720722; Hata et al, 2019, PMID: 31024045, Alimohamed et al, 2023, PMID: 36270459, Shen C. et al. 2022, PMID: 35284542, Escobar-Lopez L. et al. 2021, PMID 34674813, Pugh TJ, et al. 2014, PMID: 24503780). A variant (S151A) in this gene segregated with disease in 2 additional family members. However, the S151A variant occurs too frequently to explain disease and alternative genetic causes of disease in the family were not ruled out. This gene-disease relationship has been studied in at least one case-control study (Mazzarotto et al, 2020, PMID: 31983221) at the aggregate variant level. There was no enrichment of SGCD found in the DCM cohort compared to controls (p=0.74). In addition, this gene-disease association is supported by multiple animal models (pig, hamster, mouse and drosophila), expression studies, and rescue studies in two mouse models. SGCD has also been implicated in autosomal recessive Limb Girdle Muscular Dystrophy (LGMD) which has been assessed separately (definitive, November 14, 2024). \n\nNo convincing evidence for a causal role SGCD and AR DCM has been reported. Although this gene-disease assertion is supported by experimental evidence, there is not convincing evidence directly implicating this gene in humans. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on 30th March 2025 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ce5876bb-0bb1-4912-974f-f0522cb3de9d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40","calculatedEvidenceStrength":"Limited","changes":{"id":"cg:classificationChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-10-15T13:20:02.248Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-03-28T16:00:00.000Z","role":"Approver"}],"curationReasonDescription":"Classification was reduced to no known disease relationship due to limited convincing human genetic evidence. ","curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ac9b763-e1e4-4048-93f9-04f7f7b9ec54","type":"EvidenceLine","dc:description":"Variant MAF exceeds the 0.0001 cutoff per DCM GCEP scoring guidance. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ac9b763-e1e4-4048-93f9-04f7f7b9ec54_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/d5b835f0-633b-4e51-b3e2-554f9ce521fd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.699+18C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA142644"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7fe15e2c-0ad1-467f-93d6-d1db0e8c4cfe","type":"EvidenceLine","dc:description":"Variant MAF exceeds the 0.0001 cutoff per DCM GCEP scoring guidance","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fe15e2c-0ad1-467f-93d6-d1db0e8c4cfe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/1545d4d3-2de0-437c-87c1-e7370f697d39","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.451T>G (p.Ser151Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA119347"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d765bfc0-56cf-44ef-9587-12bea63d5ba8","type":"EvidenceLine","dc:description":"Synonymous protein change with variant MAFs exceeding the 0.0001 cutoff per DCM GCEP scoring guidance","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d765bfc0-56cf-44ef-9587-12bea63d5ba8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c62c298-0c33-434f-b7ef-8c271ca19448","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.123C>G (p.Leu41=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA142617"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/03754aa3-5f95-4278-a053-a3e75039f3a1","type":"EvidenceLine","dc:description":"Proband also carries a P variant in LMNA (c.16C>T, p.Gln6X). SGCD variant MAF exceeds the 0.0001 cutoff per DCM GCEP scoring guidance, synonymous protein change","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03754aa3-5f95-4278-a053-a3e75039f3a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/ba2b112b-68e0-4b4b-b03a-31bc5327b61c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.213G>A (p.Arg71=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA142621"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33f45adb-cadb-467c-9b78-d9e5359e6412","type":"EvidenceLine","dc:description":"There was no difference in the number of variants identified between the cases and controls.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33f45adb-cadb-467c-9b78-d9e5359e6412_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","rdfs:label":"Mazzarotto et al.","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/234f04e5-08b7-49f4-9a74-5d2d7670bc6a","type":"Cohort","allGenotypedSequenced":1040,"alleleFrequency":0.001923076923076923,"detectionMethod":"Cohort underwent targeted sequencing of 174 genes using the Illumina TruSight Cardio Sequencing Kit","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33f45adb-cadb-467c-9b78-d9e5359e6412_cc_evidence_item"}],"numWithVariant":2,"relatedCondition":{"id":"obo:MONDO_0005021"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/db7c470d-e284-4e94-9b83-1f632adee8b1","type":"Cohort","allGenotypedSequenced":912,"alleleFrequency":0.002192982456140351,"detectionMethod":"Cohort underwent targeted sequencing of 174 genes using the Illumina TruSight Cardio Sequencing Kit","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33f45adb-cadb-467c-9b78-d9e5359e6412_cc_evidence_item"}],"numWithVariant":2},"method":{"id":"cg:AggregateVariantAnalysis"},"pValue":0.735215008,"statisticalSignificanceType":"Burden testing","statisticalSignificanceValue":0.000269906,"statisticalSignificanceValueType":"Other"}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5340a0ea-8dc8-4098-83a2-d1360735d088","type":"EvidenceLine","dc:description":"Proband also carries a LP variant in DSP (c.2848_2849insA, p.Ile950AsnfsX3)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5340a0ea-8dc8-4098-83a2-d1360735d088_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9884e48-df42-4ed6-9820-02bea27360bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.731C>T (p.Pro244Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA132469"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/04a6cd4c-0486-47be-b1f5-d7673c0055d3","type":"EvidenceLine","dc:description":"Proband also carries a P variant in RBM20 (c.1913C>T, p.Pro638Leu)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04a6cd4c-0486-47be-b1f5-d7673c0055d3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/b038ed84-b9c2-45ed-b02b-ac8929a0f3f3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.390del (p.Ala131ProfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA344697"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/46eee6da-23af-4b08-bd9a-c4fe94e4edbf","type":"EvidenceLine","dc:description":"Synonymous protein change","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46eee6da-23af-4b08-bd9a-c4fe94e4edbf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/c304eba3-c750-460c-946b-17ad3e3acbae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.393C>T (p.Ala131=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA142630"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c3e79296-71c3-4ea8-808e-497900e45445","type":"EvidenceLine","dc:description":"Variant MAF exceeds the 0.0001 cutoff per DCM GCEP scoring guidance.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3e79296-71c3-4ea8-808e-497900e45445_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/89bb4f96-428f-4ad7-8cda-4f9760bc65a0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.394G>A (p.Val132Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA180989"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/54e75d09-5cb6-4818-9c00-0ba7c564a182","type":"EvidenceLine","dc:description":"0.1 (splice variant) + 0.1 (minigene assay, reduced from default of 0.4 because there is no evidence to show loss of function as a cause of AD DCM","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54e75d09-5cb6-4818-9c00-0ba7c564a182_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33662488","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b92cc83-3425-4642-aa59-e9a546729499","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.4-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362007486"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/54e75d09-5cb6-4818-9c00-0ba7c564a182_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Minigene assay supporting splicing impact (partial intron 2 retention/partial exon 3 skipping) as in frame insertion or deletion. (PMID: 36270459)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/06fe4cfd-3309-424a-afb9-ab0001e02213","type":"EvidenceLine","dc:description":"Synonymous protein change with variant MAFs exceeding the 0.0001 cutoff per DCM GCEP scoring guidance","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06fe4cfd-3309-424a-afb9-ab0001e02213_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c62c298-0c33-434f-b7ef-8c271ca19448"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9f235b61-e4ec-47a0-b337-6b6c6c8d5f4b","type":"EvidenceLine","dc:description":"Proband also carries a VUS in NEXN (c.1407_1409delAGA, p.Glu470del)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f235b61-e4ec-47a0-b337-6b6c6c8d5f4b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/65836fd1-d473-4375-9222-00a57bb7fa12","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.839C>A (p.Ser280Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA132472"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e70b3f60-cb6c-4fcc-b174-b95de6385749","type":"EvidenceLine","dc:description":"Synonymous protein change with variant MAFs exceeding the 0.0001 cutoff per DCM GCEP scoring guidance","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e70b3f60-cb6c-4fcc-b174-b95de6385749_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c62c298-0c33-434f-b7ef-8c271ca19448"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/98035c48-b0b7-4736-aa8b-6a691ee633ce","type":"EvidenceLine","dc:description":"Synonymous protein change with variant MAFs exceeding the 0.0001 cutoff per DCM GCEP scoring guidance","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98035c48-b0b7-4736-aa8b-6a691ee633ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c62c298-0c33-434f-b7ef-8c271ca19448"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/712fad85-392a-48a4-ac30-9cd01aa23f20","type":"EvidenceLine","dc:description":"Variant MAF exceeds the 0.0001 cutoff per DCM GCEP scoring guidance. In-frame deletion.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/712fad85-392a-48a4-ac30-9cd01aa23f20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b303501-db48-4642-890d-c3f0e4820861","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000337.6(SGCD):c.699+13_699+15del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA142642"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cf18a9e5-fe4d-45b4-b686-ad8e09e25f18","type":"EvidenceLine","dc:description":"Variant MAF exceeds the 0.0001 cutoff per DCM GCEP scoring guidance. In-frame deletion.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf18a9e5-fe4d-45b4-b686-ad8e09e25f18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b303501-db48-4642-890d-c3f0e4820861"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9ea90ca-5423-4fa5-a903-791be3e572e1_family_segregation","type":"FamilyCosegregation","dc:description":"Segregation not scored as did not meet the minimum criteria of 4 or more segregation in AD inheritance","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10974018","rdfs:label":"FDCM no.1100","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e9ea90ca-5423-4fa5-a903-791be3e572e1","type":"Family","rdfs:label":"FDCM no.1100"},"meetsInclusionCriteria":false,"phenotype":{"id":"obo:HP_0001644"},"phenotypePositiveAllelePositive":3},{"id":"https://genegraph.clinicalgenome.org/r/185a5532-ca29-49d5-97f5-a12be5c7d04e_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19259135","rdfs:label":"Bauer et al. Family","family":{"id":"https://genegraph.clinicalgenome.org/r/185a5532-ca29-49d5-97f5-a12be5c7d04e","type":"Family","rdfs:label":"Bauer et al. Family"},"phenotype":{"id":"obo:HP_0006785"},"phenotypePositiveAllelePositive":0},{"id":"https://genegraph.clinicalgenome.org/r/de802928-bdb1-42c1-b0f1-0593ccea05a0_proband_segregation","type":"FamilyCosegregation","dc:description":"Only one segregation to unaffected son.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14564412","rdfs:label":"Karkkainen et al Family","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/de802928-bdb1-42c1-b0f1-0593ccea05a0","type":"Family","rdfs:label":"Karkkainen et al Family","member":{"id":"https://genegraph.clinicalgenome.org/r/19bca53a-5ece-4716-8bf0-2873519193ac","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14564412","rdfs:label":"Kärkkäinen_II-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/08f919a6-a13d-4445-a3b3-41405d616eff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000005.10:g.156508620G>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3530538"}},"detectionMethod":"PCR-SSCP for SGCD, DES and metavinculin genes. Sanger sequencing of individuals with different SSCP patterns.","firstTestingMethod":"SSCP","phenotypes":["obo:HP_0005110","obo:HP_0001644"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ae1b7c0a-0686-47bd-8882-09c0d018f22d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14564412","allele":{"id":"https://genegraph.clinicalgenome.org/r/08f919a6-a13d-4445-a3b3-41405d616eff"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Left ventricular dilation with normal ejection fraction","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0005110","obo:HP_0001644"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/19bca53a-5ece-4716-8bf0-2873519193ac"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ae1b7c0a-0686-47bd-8882-09c0d018f22d","type":"EvidenceLine","dc:description":"Variant was not scored due to high MAF in Finnish ancestry (gnomAD 4.1 = 0.0002033), which exceeds the 0.0001 cutoff per DCM GCEP scoring guidance. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae1b7c0a-0686-47bd-8882-09c0d018f22d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60b84640-5c22-4d40-9c4b-c3126972c51f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5a6fae5-847c-4568-9ccf-dcc01f3add6b","type":"Finding","dc:description":"Used northern blot and western blots to identify SCGD in  human cardiac, skeletal and smooth muscle.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8842738","rdfs:label":"Northern and Western blots","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/720248bf-982d-486f-9847-800b3017824e","type":"EvidenceLine","dc:description":"Functional data has no direct relationship to DCM phenotype.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67ce8054-c304-496c-9ba4-e1082296a15a","type":"FunctionalAlteration","dc:description":"Mutant sgcd can be expressed in rat cardiac myocytes, traffics to plasma membrane and alters plasma membrane stability with mechanical strain.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26968544","rdfs:label":"Campbell et al. sgcd p.R71T and p.R97Q studies"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/59326e1b-5cc1-4dfe-8d67-3379aa305c40_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36055390-3f5a-4004-be50-85270fe36b26","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f830794-6c0f-4da7-aa21-bcdd92fa5e65","type":"Finding","dc:description":"Both WT and p.S151A cDNA was able to prevent the decline in left ventricular function compared with control sgcd -/- mice at 1 year of age.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23695275","rdfs:label":"Rutschow et al. Rescue Expt","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1b1c2ef7-b847-46f8-84ae-5e29788cb06b","type":"EvidenceLine","dc:description":"The default score of 2 was reduced to 1 as homozygous knockout best recapitulates AR inheritance rather than heterozygous AD inheritance","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c708df01-5e38-4261-8cbd-ef02b98e8fca","type":"Finding","dc:description":"DCM is characterized by decreased EF and increased ventricular size, which is recapitulated in the pig model.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32060408","rdfs:label":"Matsunari_Pig model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/82baf444-d748-47e6-b7ca-4b5c034668e4","type":"EvidenceLine","dc:description":"Compete knock out of SGCD in an autosomal recessive inheritance model. Models AR SGCD human disease but it is unclear how well this represents AD human disease.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ac79a77-aace-4b5b-962b-f11817054115","type":"Finding","dc:description":"Severe cardiomyopathy developed after 3 months of age. Also displayed severe muscular dystrophy. Similar to the AR inherited SGCD limb girdle muscular dystrophy.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10481911","rdfs:label":"Coral-Vazquez et al. Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/12529fe3-ad88-4013-8535-b60542316fd8","type":"EvidenceLine","dc:description":"No DCM phenotype.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9fae6b07-0425-462f-bc4d-2cdef476d3fa","type":"Finding","dc:description":"Male C57BL/6 mice with heterozygous knock-in of S151A showed cardiac enlargement in 1 yo mice but maintained cardiac function, no histological differences at this age.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23695275","rdfs:label":"Rutschow et al. Mouse S151A model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6569fda3-eb2f-459f-8430-30663545067d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/698da9cc-8a89-4e4d-9d51-3750ffb14f95","type":"Finding","dc:description":"Mice with gene transfer of wt sgcd showed reconstitution of sarcoglycan complex in the heart and prevention of cardiac fibrosis. Expression of sgcd prevented the deterioration of left ventricular function in the mice compared to GFP controls.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19218289","rdfs:label":"Goehringer et al. Mouse rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8332b791-414c-44db-8b8d-0f5ff9a34280","type":"EvidenceLine","dc:description":"Compete knock out of SGCD in an autosomal recessive inheritance model. Models AR SGCD human disease but it is unclear how well this represents AD human disease.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7713e643-c8ad-4f4e-8968-8a5e0095af04","type":"Finding","dc:description":"The TO-2 hamster line develops dilated cardiomyopathy (DCM) and muscular dystrophy as an autosomal recessive (AR) trait. This has been shown to be due to deletion of sgcd and loss of protein expression. Human patients with AR inheritance of SGCD variants also develop DCM and muscular dystrophy. Autosomal dominant inheritance of SGCD variants in DCM is still unclear.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9391120","rdfs:label":"Sakamoto et al. sgcd Hamster model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ac0b6ba1-081c-4e86-80f2-7ceeb64f5fd5","type":"EvidenceLine","dc:description":"Data provided in PMID 23695275 in a heterozygous knock-in mouse suggests only a mild phenotype of this variant in heterozygous individuals and the ability of S151A containing DNA to rescue the sgcd-/- DCM phenotype. The severe phenotype shown in these over-expression studies is not consistent with this data.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3362b0d9-6d9c-4985-b527-c2676edcb959","type":"Finding","dc:description":"Mice developed DCM at young age with enhanced lethality. Nuclear rather than plasma membrane localisation of SGCD. Creates trafficking defects that disrupt nuclear localisation of lamin A/C and emerin.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17164264","rdfs:label":"Heydemann et al. Mouse p.S151A","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/92e748e9-9cc9-439d-9cbb-d8c33ddd63a2","type":"EvidenceLine","dc:description":"Data provided in PMID 23695275 in a heterozygous knock-in mouse suggests only a mild phenotype of this variant in heterozygous individuals and the ability of S151A containing DNA to rescue the sgcd-/- DCM phenotype. The severe phenotype shown in these over-expression studies is not consistent with this data.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/999c02f5-0868-447d-87b8-e0e07f4ad2b4","type":"Finding","dc:description":"The flies developed a dilated cardiomyopathy with impaired systolic function with enlarged diastolic parameters.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16432241","rdfs:label":"Wolf et al. Drosophilia p.S151A","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"NoKnownDiseaseRelationship","sequence":12021,"specifiedBy":"GeneValidityCriteria10","strengthScore":4.75,"subject":{"id":"https://genegraph.clinicalgenome.org/r/9KqlMO3ArW4","type":"GeneValidityProposition","disease":"obo:MONDO_0005021","gene":"hgnc:10807","modeOfInheritance":"obo:HP_0000006"},"version":"3.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_59326e1b-5cc1-4dfe-8d67-3379aa305c40-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}